We are pleased to share that Derek Gooderham, our Chief Commercial Officer, has been appointed to the Allumiqs Board of Directors. Since joining us in 2023, Derek has been pivotal in driving our commercial growth through innovative sales, marketing, and strategic initiatives. Join us in congratulating Derek on this well-deserved new role at Allumiqs! #Leadership #Allumiqs #BoardOfDirectors #StrategicGrowth https://lnkd.in/eSzYcjMA
Allumiqs
Biotechnology Research
Halifax, Nova Scotia 1,010 followers
Bold science. Beyond data. Better together.
About us
Allumiqs is a strategic, outsourced CRO partner delivering multiomics, mass spectrometry, and data-driven solutions to help our biopharma and life sciences customers accelerate scientific discoveries and get to market faster.
- Website
-
http://www.allumiqs.com
External link for Allumiqs
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Halifax, Nova Scotia
- Type
- Privately Held
Locations
-
Primary
1344 Summer Street
Halifax, Nova Scotia B3H 0A8, CA
-
975 rue Léon-Trépanier
Sherbrooke, PQ J1G 5J6, CA
Employees at Allumiqs
-
Lovel Dhir, CHRP
Strategic Human Resources Partner | Enhancing employee experience, engagement and workplace culture | Creating success thru diversity #D&I #HR
-
Victoria Miller PhD
Research and Development at Allumiqs
-
Kent MacLean
CEO & Director of Allumiqs Corporation | CEO & Director of Allumiqs Solutions Inc. | Director of Arcos Technologies Inc.
-
Derek Gooderham
Chief Commercial Officer & Director of Allumiqs | Director of Arcos Technologies
Updates
-
We’re gearing up for an exciting Fall, with our team traveling 🌊 coast to coast 🌊 for key industry events! We’ll kick things off next week at Life Sciences Nova Scotia BioPort Atlantic in Halifax, NS. October will take us to the Boston area for some fantastic biotech community events, including the biocrates life sciences ag + Allumiqs BioPharma Day—stay tuned for the details. After that, we’ll head to Salt Lake City for American Association of Pharmaceutical Scientists (AAPS) | @aapscomms PharmSci360 with our partner Prolytix, and wrap up the season at American Society of Human Genetics Annual Conference in Denver this November. Check out our full event schedule https://lnkd.in/dGVUWCD4 and let’s connect in person soon! #multiomics #drugdevelopment #proteomics #metabolomics
Events – Allumiqs
allumiqs.com
-
Ensuring your data meets the highest standards of accuracy, completeness, and consistency is crucial for any research project. Our approach to data goes beyond the basics—we provide standard statistical analysis, visual tools, and exploratory statistics. But we don't stop there. We tailor our analysis to align with your study’s specific goals, ensuring the data not only meets your objectives but uncovers key insights that you can use to drive your research forward. Our team of scientists and data experts collaborate with you to refine the exploration of your data and reveal trends in data sets to guide the next steps of your project. Learn more ➡ https://lnkd.in/g-cQezrU #DataQuality #ResearchInnovation #ActionableInsights #ScientificExcellence
Data Analytics – Allumiqs
allumiqs.com
-
Understanding how drugs interact at the molecular level is crucial in the drug discovery process. The therapeutic effects of certain drug products depend on their ability to specifically bind to target proteins and regulate their functions. When these interactions are not optimal, it can lead to harmful side effects. Quantitative proteomics provides a powerful approach to studying these interactions. By leveraging advanced sample preparation techniques, mass spectrometry (MS) workflows and automation, we can measure changes in protein stability following drug treatment. This enables us to identify direct targets and understand the downstream regulatory pathways involved, offering deeper insights into drug mechanisms and potential impacts. ⬇ Learn more about our approach ⬇ https://lnkd.in/evQYKZ-9 #DrugDiscovery #Proteomics #MassSpectrometry #BiotechInnovation
Drug Mechanism of Action – Allumiqs
allumiqs.com
-
Navigating the complexities of biological systems requires more than just data. It demands a comprehensive approach. Each multiomics project is customized to meet your unique research goals, using cutting-edge mass spectrometry technology. The process starts with meticulous sample preparation, from extracting metabolites and lipids to protein digestion. Then comes an in-depth quantification of molecules using tried and tested LCMS methods ensuring that each type of omics data is of the highest quality. But it doesn’t stop there. The omics data is integrated with advanced bioinformatics and can be merged with other datasets like metadata or genomics studies. This holistic approach uncovers insights that might otherwise remain hidden, helping you answer the most challenging biological questions. ⬇ Learn more about our multiomics capabilities ⬇ https://lnkd.in/e_e_WWhm #Multiomics #MassSpectrometry #Bioinformatics #BoldScience
Multiomics – Allumiqs
allumiqs.com
-
Plasma biomarker discovery experiments are at the forefront of drug development efforts. However, this matrix's very high dynamic range of protein concentration can make it challenging to analyze using mass spectrometry. With the #Proteograph ™ from Seer in combination with DIA mass spectrometry, we are reliably and reproducibly quantifying thousands of proteins per sample for our customers. Not to mention one of the most interesting aspects of this workflow that allows us to access post-translational modifications (PTMs), pQTLs, isoforms, and more as the readings are done on the protein themselves, and not the nucleic acid or fluorescent reporters. Looking for new ways to advance your drug development or want to take the Proteograph™ for test drive? Let’s connect to chat about our plasma biomarker discovery solutions enabled by the Proteograph™. https://lnkd.in/e6gpieUc #PlasmaBiomarkers #Proteomics #DrugDevelopment #MassSpectrometry
Biomarker Discovery – Allumiqs
allumiqs.com
-
Metabolic abnormalities often disrupt key pathways, leading to significant health challenges. The accumulation or deficiency of specific metabolites is a hallmark of many diseases, providing crucial clues for diagnosis, prognosis, and treatment strategies. Small molecule metabolomics has emerged as a vital tool in the discovery of metabolic biomarkers and pathway analysis. With untargeted metabolomics, it's possible to identify up to 60,000 features in a sample, narrowing down to the most relevant 100s with high potential for biomarker discovery. On the other hand, targeted approaches offer precise quantification of selected molecules, using internal standards for accuracy. By leveraging retention time and MS/MS ion-ratio to commercially available identified standards, we can achieve accurate metabolite identification and uncover structural features, enhancing our understanding of disease mechanisms. ⬇Learn more about our capabilities here ⬇ https://lnkd.in/dSPtTDij #UntargetedMetabolomics #MetabolicBiomarkerDiscovery #OmicsScience
Metabolomics – Allumiqs
allumiqs.com
-
Protein phosphorylation plays a crucial role in cellular signaling and the regulation of cellular networks. However, due to the dynamic nature of phosphorylation and the low abundance of phosphoproteins, mapping and analyzing these modifications is a challenging task. MagReSyn® beads are specifically designed to bind and enrich phosphopeptides, providing a reliable matrix for their isolation. These phosphopeptides are then ready for detailed analysis using mass spectrometry, enabling deeper insights into phosphorylation patterns within your samples. MagReSyn® Ti-IMAC microparticles feature a flexible linker that reduces steric hindrance, allowing the Ti4+ ions to effectively bind the phosphonate groups on phosphopeptides. Once bound, the phosphopeptides are isolated using a magnet, allowing the remaining proteins to be washed away. These microparticles can be used alone or in combination with MagReSyn® TiO2, Zr-IMAC, and/or ZrO2 to maximize phosphoproteome coverage. For even greater performance, the new High Performance (HP) versions of Zr-IMAC and Ti-IMAC offer increased yield and enhanced sample coverage, making phosphopeptide enrichment more effective than ever. ⬇ Explore MagReSyn® beads here ⬇ https://lnkd.in/dS_SmZjc #MagReSyn #Enrichment #BoldScience
Magnetic Beads – Allumiqs
allumiqs.com
-
Working with complex biological matrices like serum, plasma, urine, CSF, and cell cultures can be challenging. That’s why we’re proud to distribute MagReSyn® SAX beads—high-capacity magnetic microparticles designed for the efficient purification of proteins, peptides, enzymes, and antibodies. MagReSyn® SAX is a powerful anionic exchanger that excels at fractionating complex biological samples. For example, when introduced to plasma, these beads bind negatively charged extracellular vesicles (EVs), which are then immobilized with a magnet, allowing abundant plasma proteins to be washed away without losing your target molecules. The bound particles are lysed directly on the beads, with proteins reduced and alkylated to ensure optimal preparation for enzymatic digestion with trypsin. Post-digestion, the peptides are collected and analyzed via LC-MS/MS, revealing insights into EV proteins and their biology. ⬇ Learn more about the MagResyn Technology here ⬇ https://lnkd.in/eFEpTu3W #Proteomics #MagReSyn #Biotech #ResearchInnovation
Magnetic Beads – Allumiqs
allumiqs.com
-
We're proud to be the first certified lab partner of biocrates life sciences ag in North America, marking a new era in targeted metabolomics analysis. Our collaboration is set to redefine what's possible in metabolite research, enhancing both accessibility and quality of data insights. Utilizing the cutting-edge Absolute IDQ® p400 HR kit, our workflows are designed for precision and efficiency. This powerful tool allows us to quantify over 400 key metabolites and lipids from 11 crucial compound classes, all vital to understanding central metabolic pathways. What sets us apart? Our capabilities extend to high-throughput analysis, allowing us to process up to 240 metabolites weekly with a minimal sample requirement of just 10ul for most biofluids, ensuring that even limited sample volumes yield significant data. Additionally, our methodologies are refined to deliver consistent, reliable results every time, underlining our commitment to reproducibility and precision. Our goal is to empower researchers and innovators by providing deep, actionable insights into the metabolic processes that drive biological systems. Whether you’re studying disease mechanisms or exploring new therapeutics, our targeted metabolomics services are here to accelerate your research and enhance your outcomes. #Allumiqs #Metabolomics #MassSpectrometry #InnovationInResearch
Allumiqs expands metabolomics solutions as part of the biocrates Certified Laboratory Program – Allumiqs
allumiqs.com